# Superstring Capital Management LP 13F Q2 2026: $158 million

Checked November 20, 2026.

Superstring Capital Management LP reported $158 million in 13F securities across 32 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Cogent Biosciences Inc at $13.3 million, 8.4% of the reported value. Since Q1 2026 it opened 8 new positions and exited 11.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $158,379,902
- Positions: 32
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1931118
- Form 13F file number: 028-23866
- Business address: 150 E. 52nd St Suite 5004, New York, NY 10022
- SEC filing: [0001931118-26-000009](https://www.sec.gov/Archives/edgar/data/1931118/000193111826000009/0001931118-26-000009-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/superstring-capital-management-lp-305743)

## Top 25 holdings by value

The largest of 32 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 343,284 | $13.3 million | +118,126 |
| [Axsome Therapeutics Inc.](https://specstream.ai/data/institutional-holders/axsome-therapeutics-inc-05464t104) | COM | 53,916 | $13.2 million | +42,699 |
| [Genmab A/S](https://specstream.ai/data/institutional-holders/genmab-a-s-372303206) | SPONSORED ADS | 430,600 | $11.8 million | +233,891 |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 287,583 | $10.7 million | +107,535 |
| [Trevi Therapeutics Inc](https://specstream.ai/data/institutional-holders/trevi-therapeutics-inc-89532m101) | COM | 524,224 | $9.8 million | +272,658 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 51,053 | $9.6 million | New |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 188,282 | $8.9 million | -163,179 |
| [Vir Biotechnology Inc](https://specstream.ai/data/institutional-holders/vir-biotechnology-inc-92764n102) | COM | 853,685 | $8.7 million | +123,137 |
| [Immunovant Inc](https://specstream.ai/data/institutional-holders/immunovant-inc-45258j102) | COM | 208,368 | $8 million | -149,238 |
| [Urogen Pharma LTD](https://specstream.ai/data/institutional-holders/urogen-pharma-ltd-m96088105) | COM | 191,313 | $7 million | -196,058 |
| [Climb Bio Inc](https://specstream.ai/data/institutional-holders/climb-bio-inc-28658r106) | COM | 521,082 | $6.8 million | +321,873 |
| [Adlai Nortye LTD](https://specstream.ai/data/institutional-holders/adlai-nortye-ltd-00704r109) | SPONSORED ADS | 552,501 | $6.4 million | +137,649 |
| [Savara Inc](https://specstream.ai/data/institutional-holders/savara-inc-805111101) | COM | 977,460 | $6 million | -608,517 |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 125,432 | $4.5 million | -66,707 |
| [Oric Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/oric-pharmaceuticals-inc-68622p109) | COM | 406,077 | $4.4 million | +290,843 |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 7,172 | $3.9 million | +1,986 |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 66,793 | $3.9 million | -43,661 |
| [Beone Medicines LTD](https://specstream.ai/data/institutional-holders/beone-medicines-ltd-07725l102) | SPONSORED ADS | 12,273 | $3.5 million | New |
| [Cabaletta Bio Inc](https://specstream.ai/data/institutional-holders/cabaletta-bio-inc-12674w109) | COM | 1,278,652 | $3.5 million | +212,413 |
| [Zai Lab LTD](https://specstream.ai/data/institutional-holders/zai-lab-ltd-98887q104) | ADR | 155,813 | $3 million | -120,005 |
| [Sionna Therapeutics Inc](https://specstream.ai/data/institutional-holders/sionna-therapeutics-inc-829401108) | COM | 63,156 | $2.8 million | -77,868 |
| [Bright Minds Biosciences Inc](https://specstream.ai/data/institutional-holders/bright-minds-biosciences-inc-10919w405) | COM NEW | 30,456 | $2.1 million | +17,145 |
| [Aclaris Therapeutics Inc](https://specstream.ai/data/institutional-holders/aclaris-therapeutics-inc-00461u105) | COM | 257,675 | $1.4 million | -108,815 |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 204,424 | $1.4 million | New |
| [Kiniksa Pharmaceuticals Intl](https://specstream.ai/data/institutional-holders/kiniksa-pharmaceuticals-intl-g52694109) | ORD SHS CL A | 18,867 | $1.2 million | New |

## New positions in Q2 2026

8 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 51,053 | $9.6 million |
| [Beone Medicines LTD](https://specstream.ai/data/institutional-holders/beone-medicines-ltd-07725l102) | SPONSORED ADS | 12,273 | $3.5 million |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 204,424 | $1.4 million |
| [Kiniksa Pharmaceuticals Intl](https://specstream.ai/data/institutional-holders/kiniksa-pharmaceuticals-intl-g52694109) | ORD SHS CL A | 18,867 | $1.2 million |
| [Roivant Sciences LTD](https://specstream.ai/data/institutional-holders/roivant-sciences-ltd-g76279101) | SHS | 25,623 | $906,798 |
| [Faeth Therapeutics Inc](https://specstream.ai/data/institutional-holders/faeth-therapeutics-inc-81728a207) | COM NEW | 14,175 | $354,375 |
| [Boundless Bio Inc](https://specstream.ai/data/institutional-holders/boundless-bio-inc-10170a100) | COM | 55,356 | $138,390 |
| [Vyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/vyne-therapeutics-inc-92941v308) | COM | 61,269 | $39,868 |

## Positions exited in Q2 2026

11 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Summit Therapeutics Inc](https://specstream.ai/data/institutional-holders/summit-therapeutics-inc-86627t108) | COM | 892,873 | $16.9 million |
| [Vertex Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/vertex-pharmaceuticals-inc-92532f100) | COM | 11,010 | $4.9 million |
| [Iqvia Hldgs Inc](https://specstream.ai/data/institutional-holders/iqvia-hldgs-inc-46266c105) | COM | 25,668 | $4.4 million |
| [Arvinas Inc](https://specstream.ai/data/institutional-holders/arvinas-inc-04335a105) | COM | 312,620 | $3.3 million |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 63,591 | $3.1 million |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422g107) | COM | 102,754 | $3.1 million |
| [Pfizer Inc](https://specstream.ai/data/institutional-holders/pfizer-inc-717081103) | COM | 74,000 | $2.1 million |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 258,269 | $1.2 million |
| [Cullinan Therapeutics Inc](https://specstream.ai/data/institutional-holders/cullinan-therapeutics-inc-230031106) | COM | 59,484 | $845,268 |
| [Palatin Technologies Inc](https://specstream.ai/data/institutional-holders/palatin-technologies-inc-696077601) | COM NEW | 35,969 | $626,580 |
| [Century Therapeutics Inc](https://specstream.ai/data/institutional-holders/century-therapeutics-inc-15673t100) | COM | 119,308 | $269,636 |

## Also on SpecStream

- [Superstring Capital Management LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1931118/000193111826000009/0001931118-26-000009-index.htm)
- [Superstring Capital Management LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/superstring-capital-management-lp-305743)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Apparel manufacturers in New York, New York](https://specstream.ai/data/businesses/apparel-manufacturers/new-york-new-york-united-states)
- [Mexican restaurants in New York, New York](https://specstream.ai/data/businesses/mexican-restaurants/new-york-new-york-united-states)
- [Commercial printers in New York, New York](https://specstream.ai/data/businesses/commercial-printers/new-york-new-york-united-states)
- [Recycling centers in New York, New York](https://specstream.ai/data/businesses/recycling-centers/new-york-new-york-united-states)
- [Food and beverage distributors in New York, New York](https://specstream.ai/data/businesses/food-and-beverage-distributors/new-york-new-york-united-states)
- [Wholesalers in New York, New York](https://specstream.ai/data/businesses/wholesalers/new-york-new-york-united-states)
